Marie Tauber, MD a, Sébastien Buche, MD b, Pascal Reygagne, MD c, Jean-Marie Berthelot, MD d, François Aubin, MD, PhD e, Pierre-Dominique Ghislain, MD f, Jean-David Cohen, MD g, Pascal Coquerelle, MD h, Elisa Goujon, MD i, Denis Jullien, MD, PhD j, Hedia Brixi, MD k, Géraldine Jeudy, MD l, Xavier Guennoc, MD m, Antoine Martin, MD m, Emilie Brénaut, MD n, Emmanuel Hoppé, MD o, Antoine Bertolotti, MD p, Thomas Bardin, MD, PhD q, Emmanuel Delaporte, MD b, Matthieu Allez, MD, PhD r, Hervé Bachelez, MD, PhD a, Julien Seneschal, MD, PhD p, Manuelle Viguier, MD, PhD a, ⁎
On behalf of theGroupe de Recherche sur le Psoriasis de la Société Française de, Dermatologie, the Club Rhumatismes et Inflammation (CRI) and the Groupe d’études thérapeutiques des affections inflammatoires du tube digestif (GETAID)
a Paris VII Denis-Diderot University, Assistance Publique-Hôpitaux de Paris (AP-HP), Dermatology Department, Hôpital Saint-Louis, Paris, France
b Dermatology Department, Centre Hospitalo-Universitaire (CHU), Lille, France
c Centre Sabouraud, Hôpital Saint-Louis, Paris, France
d Rheumatology Department, CHU, Nantes, France
e Dermatology Department, CHU, Besançon, France
f Dermatology Department, Hôpital Louvain, Brussels, France
g Rheumatology Department, CHU, Montpellier, France
h Rheumatology Department, Centre Hospitalier Régional (CHR), Béthune, France
i Dermatology Department, CHR, Chalon sur Saône, France
j Dermatology Department, CHU, Lyon, France
k Gastroenterology Department, CHU, Reims, France
l Dermatology Department, CHU, Dijon, France
m Rheumatology Department, CHR, Saint-Brieuc, France
n Dermatology Department, CHU, Brest, France
o Rheumatology Department, CHU, Angers, France
p Dermatology Department, Hôpital Saint André, Bordeaux, France
q Paris VII Denis-Diderot University, AP-HP, Rheumatology Department, Hôpital Lariboisière, Paris, France
r Paris VII Denis-Diderot University, AP-HP, Gastroenterology Department, Hôpital Saint-Louis, France